ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARP Annual Meeting 2019

Abstract Number: 216

Does Fibromyalgia Change the Evaluation of Spondyloarthritis Activity? A Meta-analysis of Observational Studies

Arthur Beck1, Lilian SOLE 1, Thomas Barnetche 2 and Pascale Vergne-Salle 1, 1CHU de LIMOGES, LIMOGES, France, 2CHU de BORDEAUX, BORDEAUX, France

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARP Annual Meeting 2019

Keywords: fibromyalgia, spondylarthritis and spondylarthropathy

Session Information

Date: Sunday, November 10, 2019

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent studies evaluated the prevalence of Fibromyalgia (FM) in Spondyloarthritis (SpA) and its impact on disease activity scores, but none meta-analysis exists yet. Therefore, we performed a meta-analysis to evaluate the impact of fibromyalgia on activity scores in SpA.

Methods: We performed a systematic review of the literature until May 2019 using database including: MEDLINE (via PUBMED), EMBASE and abstracts from the ACR and EULAR congresses 2016-2019. We selected observational studies comparing characteristics of SpA patients (defined by ASAS, NY modified or CASPAR criteria) with or without fibromyalgia (defined by ACR 1990, 2011 fibromyalgia criteria or FiRST survey).

Two readers extracted the prevalence of FM in SpA, female ratio, HLAB27 status, disease duration, radiographic sacroiliitis, C-reactive protein (CRP), BASDAI, BASFI, ASDAS-CRP and Quality of Life (QoL).

Statistical analysis determined in each study theeffect size. Data was analyzed using the inverse variance approach.

Results: The literature search identified 433 articles. Finally, 15 studies met the inclusion criteria.

The prevalence of FM in SpA was 17% IC95% [0.12, 0.23] with a significant female ratio of 5.13 IC95%[3.02, 8.70]in SpA with FM.

FM impacted significantly all the activity scores of SpA: BASDAI: OR= 2.18 IC95%[1.45, 2.91]; BASFI: OR= 2.33 IC95%[1.65, 3.02]; ASDAS-CRP: OR= 0.54 IC95%[0.05, 1.02]; AsQoL: OR=5.50 IC95%[4.28, 6.71]

No statistical difference was found concerning HLAB27 status, disease duration and CRP level.

Conclusion: In this meta-analysis, the prevalence of FM in SpA was 17%, whereas 2-8% in general population. The coexistence of FM with SpA led to higher activity scores, including ASDAS-CRP, although CRP trends to be lower in the FM group.

Rheumatologist have to be aware of the association of FM and SpA, activity scores may be biased.

BASDAI

BASFI

ASDAS-CRP


Disclosure: A. Beck, None; L. SOLE, None; T. Barnetche, None; P. Vergne-Salle, None.

To cite this abstract in AMA style:

Beck A, SOLE L, Barnetche T, Vergne-Salle P. Does Fibromyalgia Change the Evaluation of Spondyloarthritis Activity? A Meta-analysis of Observational Studies [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/does-fibromyalgia-change-the-evaluation-of-spondyloarthritis-activity-a-meta-analysis-of-observational-studies/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-fibromyalgia-change-the-evaluation-of-spondyloarthritis-activity-a-meta-analysis-of-observational-studies/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology